We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.56B
AUM Growth
-$316M
Cap. Flow
-$742M
Cap. Flow %
-16.27%
Top 10 Hldgs %
15.49%
Holding
2,634
New
531
Increased
353
Reduced
471
Closed
900

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.7M
3
AMZN icon
Amazon
AMZN
+$22.4M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$21.7M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$18M

Top Sells

Rank Stock Value
1
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$23.1M
2
WMT icon
Walmart Inc
WMT
+$17.7M
3
BURL icon
Burlington
BURL
+$12.7M
4
ALCE
Alternus Clean Energy Inc
ALCE
+$12.1M
5
GILD icon
Gilead Sciences
GILD
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 9.63%
3 Financials 7.8%
4 Industrials 6.22%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DISTR
1626
DELISTED
Distoken Acquisition Corporation Right
DISTR
$31.2K ﹤0.01%
151,200
– –
MOBBW
1627
Mobilicom Ltd Warrants
MOBBW
$1.91B
$31.1K ﹤0.01%
20,300
– –
CNTB
1628
Connect Biopharma Holdings
CNTB
$127M
$30.4K ﹤0.01%
26,867
– –
ELDN icon
1629
Eledon Pharmaceuticals
ELDN
$261M
$30.2K ﹤0.01%
22,050
– –
ALSAR
1630
DELISTED
Alpha Star Acquisition Corp Rights
ALSAR
$28.8K ﹤0.01%
360,200
– –
BIOC
1631
DELISTED
Biocept, Inc.
BIOC
$28.5K ﹤0.01%
+23,529
New +$133K
ARIZR
1632
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$26.6K ﹤0.01%
330,000
– –
IVDAW icon
1633
Iveda Solutions Warrant
IVDAW
$26.2K ﹤0.01%
24,000
– –
TECX
1634
Tectonic Therapeutic
TECX
$529M
$25.6K ﹤0.01%
+2,241
New +$25.3K
RZLT icon
1635
Rezolute
RZLT
$454M
$23.8K ﹤0.01%
12,000
– –
HTCO
1636
High-Trend International Group
HTCO
$31.3M
$21.8K ﹤0.01%
1,669
– –
CTV.WS
1637
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$21.8K ﹤0.01%
20,000
– –
DRMAW icon
1638
Dermata Therapeutics Warrant
DRMAW
$14.1K
$19.8K ﹤0.01%
12,000
– –
TPET icon
1639
Trio Petroleum
TPET
$12.4M
$19.5K ﹤0.01%
+585
New +$19.4K
OAKUR
1640
DELISTED
Oak Woods Acquisition Corp Right
OAKUR
$18.2K ﹤0.01%
+86,600
New +$16K
NEXRW
1641
Nexera Technologies Ltd Warrant
NEXRW
$90.7K
$18K ﹤0.01%
24,038
– –
AIMDW icon
1642
Ainos Warrants
AIMDW
$17K ﹤0.01%
25,000
– –
CISS
1643
C3is
CISS
$177K
– –
0
– –
GODNR
1644
DELISTED
Golden Star Acquisition Corporation Rights
GODNR
$16K ﹤0.01%
+72,600
New +$16.9K
HMACR
1645
DELISTED
Hainan Manaslu Acquisition Corp. Right
HMACR
$14.8K ﹤0.01%
37,000
– –
HHGCR
1646
DELISTED
HHG Capital Corporation Rights
HHGCR
$14.5K ﹤0.01%
125,000
– –
SYBX
1647
DELISTED
Synlogic
SYBX
$13.3K ﹤0.01%
2,058
– –
MNK
1648
DELISTED
Mallinckrodt plc
MNK
$13K ﹤0.01%
11,038
– –
NXLIW
1649
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$12.1K ﹤0.01%
13,500
– –
BWAQR
1650
DELISTED
Blue World Acquisition Corporation Right
BWAQR
$11.9K ﹤0.01%
54,000
+37,500
+227% +$5.33K
64 65
66
67 68

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boothbay Fund Management held 2,634 positions worth $4.56B, down 6.5% from $4.87B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boothbay Fund Management withdrew a net $742M in Q2 2023, closing 900 positions and reducing 471 holdings. Its most notable exit was Alternus Clean Energy Inc, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 10% a quarter earlier, followed by Technology and Financials.

Against the trend, Boothbay Fund Management opened a new position in Indivior Pharmaceuticals worth $21.9M.

  • Boothbay Fund Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 946,208 shares worth $21.9M.
  • Boothbay Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $26.9M increase.
  • Boothbay Fund Management's biggest Q2 2023 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $23.1M.
  • Boothbay Fund Management fully exited Alternus Clean Energy Inc in Q2 2023, selling an estimated $12.1M.
  • Boothbay Fund Management's ten largest holdings make up 15% of its $4.56B portfolio in Q2 2023.
  • Boothbay Fund Management opened 531 new positions and closed 900 in Q2 2023.
  • Boothbay Fund Management's portfolio value fell 6.5% quarter-over-quarter to $4.56B.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.